TOT BIOPHARM International Company Limited (1875.HK)

HKD 2.04

(-0.49%)

Gross Profit Summary of TOT BIOPHARM International Company Limited

  • TOT BIOPHARM International Company Limited's latest annual gross profit in 2023 was 573.98 Million CNY , up 54.87% from previous year.
  • TOT BIOPHARM International Company Limited's latest quarterly gross profit in 2024 Q2 was 376.9 Million CNY , down 0.0% from previous quarter.
  • TOT BIOPHARM International Company Limited reported a annual gross profit of 370.61 Million CNY in annual gross profit 2022, up 1248.97% from previous year.
  • TOT BIOPHARM International Company Limited reported a annual gross profit of 27.47 Million CNY in annual gross profit 2021, up 76.91% from previous year.
  • TOT BIOPHARM International Company Limited reported a quarterly gross profit of 573.98 Million CNY for 2023 FY, up 54.87% from previous quarter.
  • TOT BIOPHARM International Company Limited reported a quarterly gross profit of 323.98 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Gross Profit Chart of TOT BIOPHARM International Company Limited (2023 - 2017)

Historical Annual Gross Profit of TOT BIOPHARM International Company Limited (2023 - 2017)

Year Gross Profit Gross Profit Growth
2023 573.98 Million CNY 54.87%
2022 370.61 Million CNY 1248.97%
2021 27.47 Million CNY 76.91%
2020 15.53 Million CNY -54.31%
2019 33.99 Million CNY 2.27%
2018 33.23 Million CNY -29.83%
2017 47.36 Million CNY 0.0%

Peer Gross Profit Comparison of TOT BIOPHARM International Company Limited

Name Gross Profit Gross Profit Difference
Uni-Bio Science Group Limited 392.81 Million HKD -46.12%
CK Life Sciences Int'l., (Holdings) Inc. 947.7 Million HKD 39.434%